Immunology and Microbiology
Granulomatosis with Polyangiitis
100%
ANCA Associated Vasculitis
83%
Vasculitis
58%
Autoantibodies
57%
Neutrophil Cytoplasmic Antibody
38%
Neutrophil
24%
B Cell
24%
CD4
16%
Cyclophosphamide
15%
T Cell
15%
Neutrophil Granulocyte
14%
Glomerulonephritis
14%
Staphylococcus Aureus
14%
Azathioprine
13%
ELISA
11%
Kidney Function
10%
T-Helper Cell
9%
Mycophenolic Acid
9%
Regulatory T Cell
9%
Macrophage
9%
Urinary Tract
9%
Transplant Procedure
8%
Blood Level
8%
Rituximab
8%
Memory T Cell
7%
Blood Plasma
7%
Epitope
7%
Prevalence
7%
Enzyme-Linked Immunosorbent Assay
7%
Atherosclerosis
6%
Monospecific Antibody
6%
Leukocyte
6%
BK Virus
5%
Interleukin 17
5%
Vaccination Policy
5%
Microscopic Polyangiitis
5%
Inflammatory Disorder
5%
Autoimmune Disease
5%
Influenza
5%
CD177
5%
Recurrence Free Survival
5%
Glucocorticoid
5%
Medicine and Dentistry
ANCA Associated Vasculitis
53%
Vasculitis
43%
Granulomatosis with Polyangiitis
38%
Disease
31%
Autoantibodies
24%
Neutrophil
21%
Kidney Function
18%
Glomerulonephritis
18%
Myeloblastin
17%
Myeloperoxidase
17%
Neutrophil Cytoplasmic Antibody
17%
Nephropathy
13%
Kidney Graft
11%
Kidney Transplantation
10%
Cyclophosphamide
10%
Urinary System
10%
Urinary Tract Infection
10%
Systemic Vasculitis
9%
Proteinuria
9%
In Vitro
8%
Diagnosis
7%
Influenza Vaccination
7%
Immunosuppressive Treatment
7%
Creatinine
7%
Microscopic Polyangiitis
6%
Kidney Injury
6%
Emergency Department
6%
Azathioprine
6%
Glomerular Filtration Rate
6%
Randomized Controlled Trial
6%
Maintenance Therapy
6%
Leukocyte
5%
Renal Replacement Therapy
5%
Cross Sectional Study
5%
Staphylococcus Aureus
5%
Biological Marker
5%
Disease Activity
5%
BK Virus
5%
Acute Kidney Injury
5%
Renal Biopsy
5%
Adeno-Associated Virus
5%
T Cell
5%
Sepsis
5%
Chronic Kidney Disease
5%
Biopsy
5%
Keyphrases
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
36%
ANCA-associated Vasculitis
21%
Granulomatosis with Polyangiitis
18%
Antineutrophil Cytoplasmic Antibody
16%
Proteinase 3
11%
Cyclophosphamide
9%
Remission Induction
8%
Remission
8%
Associated Vasculitis
8%
Wegener's Granulomatosis
6%
Mycophenolate Mofetil
6%
B Cells
5%
Maintenance Therapy
5%
Healthy Controls
5%
High Mobility Group Box 1 (HMGB1)
5%